News

Printer Friendly Version View printer-friendly version
<< Back
Array BioPharma To Report Financial Results For The First Quarter Of Fiscal 2015 On November 4, 2014
  

BOULDER, Colo., Oct. 29, 2014 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) will report financial results for the first quarter of fiscal 2015 and hold a conference call to discuss those results on Tuesday, November 4, 2014.  Ron Squarer, Chief Executive Officer and Michael Carruthers, Chief Financial Officer will lead the call.

Date:  

Tuesday, November 4, 2014

Time:  

9:00 a.m. Eastern Time

Toll-Free: 

(800) 708-4540

Toll: 

(847) 619-6397

Pass Code:

38177000

Webcast, including Replay and Conference Call Slides: 

http://www.media-server.com/m/acs/835a9ca60ab7df8747dc3aa3ad1d878b

About Array BioPharma Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer.  Seven Phase 3 studies are in progress, or are planned to begin this year. These programs include the wholly-owned hematology drug, filanesib (ARRY-520) for multiple myeloma and two partnered cancer drugs, selumetinib (AstraZeneca) and binimetinib (MEK162 / Novartis).  For more information on Array, please go to www.arraybiopharma.com.

CONTACT:

Tricia Haugeto


Array BioPharma Inc.


(303) 386-1193


thaugeto@arraybiopharma.com

SOURCE Array BioPharma